Continuing Access to Harvard Longitudinal Survey Data
ID: FDA_7222026 • Type: Special Notice
• Match:
100%
Opportunity Assistant
Loading
Overview
Response Deadline
Aug. 7, 2026, 3:00 p.m. EDT
Due in 15 Days
Posted
July 22, 2026, 12:35 p.m. EDT
Set Aside
8(a) Sole Source (8AN)
NAICS
PSC
None
Place of Performance
Rockville, MD 20852
United States
Source
Current SBA Size Standard
$40 Million
Pricing
Likely Fixed Price
Est. Value Range
Experimental
$250,000 - $900,000
(AI estimate)
Signs of Shaping
87% of obligations for similar contracts within the Food and Drug Administration were awarded full & open.
On 7/22/26 Food and Drug Administration issued Special Notice FDA_7222026 for Continuing Access to Harvard Longitudinal Survey Data due 8/7/26.
Primary Contact
Documents
Posted documents for Special Notice FDA_7222026
Opportunity Assistant
AI Analysis
Incumbent or Similar Awards
Potential Bidders and Partners
Awardees that have won contracts similar to Special Notice FDA_7222026
Similar Active Opportunities
Open contract opportunities similar to Special Notice FDA_7222026
Experts for Continuing Access to Harvard Longitudinal Survey Data
Recommended subject matter experts available for hire
Additional Details
Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION
FPDS Organization Code
7524-7524
Source Organization Code
100008023
Last Updated
July 22, 2026
Last Updated By
samad.sahil@fda.hhs.gov
Archive Date
Aug. 22, 2026